1,4,7-tris-(benzyloxycarbonyl)-10-(ethoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane | 752252-79-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 1,4,7-tris-(benzyloxycarbonyl)-10-(ethoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane
• 英文别名: 1,4,7-tris-(benzyloxycarbonyl)-10-(ethoxycarbonylmethyl)-1,4,7,10-tetrazacyclododecane；tribenzyl 10-(2-ethoxy-2-oxoethyl)-1,4,7,10-tetrazacyclododecane-1,4,7-tricarboxylate
• CAS: 752252-79-2
• 化学式: C₃₆H₄₄N₄O₈
• 分子量: 660.767
• InChiKey: UBZKIEBIOWOKBB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  48
• 可旋转键数：
  13
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  118
• 氢给体数：
  0
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  1,4,7-tris-(benzyloxycarbonyl)-10-(ethoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane 在 sodium hydroxide 、 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 作用下， 生成 ethyl N-({4,7,10-tris[(benzyloxy)carbonyl]-1,4,7,10-tetraazacyclododecan-1-yl} acetyl)glycinate
  参考文献：
  名称：

  Toward Protein-Cleaving Catalytic Drugs: Artificial Protease Selective for Myoglobin

  摘要：

  A protein-cleaving catalyst highly selective for a disease-related protein can be used as a catalytic drug. As the first protein-cleaving catalyst selective for a protein substrate, a catalyst for myoglobin (Mb) was designed by attaching the Cu(II) or Co(III) complex of cyclen to a binding site searched by a combinatorial method using peptide nucleic acid monomers as building units. Various linkers were inserted between the catalytic Co(III) center and the binding site of the Mb-cleaving catalyst. Kinetic data revealed catalytic turnover of the Mb cleavage by the Cu(II) or Co(III) complex. MALDI-TOF MS revealed cleavage of the polypeptide backbone of Mb at selected positions. N-Terminal sequencing of the cleavage products identified the cleavage site and provided evidence for the hydrolytic nature of the Mb cleavage. Various chelating ligands were tested as the ligand for the Co(III) center of the Mb-cleaving catalyst. Among the nine chelating ligands examined, only cyclen and its triaza-monooxo analogue manifested catalytic activity. (C) 2003 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0968-0896(03)00216-5
• 作为产物：
  描述：

  溴乙酸乙酯 、 Tribenzyl 1,4,7,10-Tetraazacyclododecane-1,4,7-tricarboxylate 在 sodium carbonate 作用下， 以 乙腈 为溶剂， 反应 20.0h， 以92%的产率得到1,4,7-tris-(benzyloxycarbonyl)-10-(ethoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane
  参考文献：
  名称：

  Trimeric macrocyclic substituted benzene derivatives

  摘要：

  具有一般公式I1的金属配合物，其中Hal代表溴或碘，而A1和A2具有不同的含义，适用于作为对比介质。

  公开号：

  US20040265236A1

文献信息

• [DE] TRIMERE MAKROCYCLISCH SUBSTITUIERTE BENZOLDERIVATE<br/>[EN] TRIMERIC MACROCYCLICALLY SUBSTITUTED BENZENE DERIVATIVES<br/>[FR] DERIVES DE BENZENE TRIMERES SUBSTITUES DE MANIERE MACROCYCLIQUE
  申请人：SCHERING AG

  公开号：WO2004074267A1

  公开（公告）日：2004-09-02

  Die Metallkomplexe der allgemeinen Formel (I), worin Hal für Brom oder Iod steht und A1 und A2 unterschiedliche Bedeutung haben, sind als Kontrastmittel geeignet.

  通用公式（I）中的金属配合物，其中Hal代表溴或碘，而A1和A2具有不同的含义，适用作为造影剂。
• US7208140B2
  申请人：——

  公开号：US7208140B2

  公开（公告）日：2007-04-24
• Trimeric macrocyclic substituted benzene derivatives
  申请人：——

  公开号：US20040265236A1

  公开（公告）日：2004-12-30

  The metal complexes of general formula I 1 in which Hal stands for bromine or iodine and A 1 and A 2 have different meanings, are suitable as contrast media.

  具有一般公式I1的金属配合物，其中Hal代表溴或碘，而A1和A2具有不同的含义，适用于作为对比介质。
• Toward Protein-Cleaving Catalytic Drugs: Artificial Protease Selective for Myoglobin
  作者：Joong Won Jeon、Sang Jun Son、Chang Eun Yoo、In Seok Hong、Junghun Suh

  DOI：10.1016/s0968-0896(03)00216-5

  日期：2003.7

  A protein-cleaving catalyst highly selective for a disease-related protein can be used as a catalytic drug. As the first protein-cleaving catalyst selective for a protein substrate, a catalyst for myoglobin (Mb) was designed by attaching the Cu(II) or Co(III) complex of cyclen to a binding site searched by a combinatorial method using peptide nucleic acid monomers as building units. Various linkers were inserted between the catalytic Co(III) center and the binding site of the Mb-cleaving catalyst. Kinetic data revealed catalytic turnover of the Mb cleavage by the Cu(II) or Co(III) complex. MALDI-TOF MS revealed cleavage of the polypeptide backbone of Mb at selected positions. N-Terminal sequencing of the cleavage products identified the cleavage site and provided evidence for the hydrolytic nature of the Mb cleavage. Various chelating ligands were tested as the ligand for the Co(III) center of the Mb-cleaving catalyst. Among the nine chelating ligands examined, only cyclen and its triaza-monooxo analogue manifested catalytic activity. (C) 2003 Elsevier Science Ltd. All rights reserved.